Our results reveal an enhanced NF-κB signaling network regulated by HOXA9, which contributes to repressed apoptosis and activated autophagy in cSCC development and may represent an intervention target for cSCC therapy. This evidence concerns the gene NFKB1 and skin squamous cell carcinoma.